| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 73.3659 | 70 |
| GSM780708 | Untreated after 4 days (C2_1) | 67.5896 | 68 |
| GSM780709 | Untreated after 4 days (C3_1) | 115.327 | 77 |
| GSM780719 | Untreated after 4 days (C1_2) | 57.9189 | 63 |
| GSM780720 | Untreated after 4 days (C2_2) | 67.5969 | 68 |
| GSM780721 | Untreated after 4 days (C3_2) | 119.428 | 78 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 75.4027 | 71 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 74.8304 | 70 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 75.3978 | 71 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 69.5936 | 69 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 75.6254 | 71 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 62.3104 | 66 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 79.2584 | 72 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 67.5239 | 68 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 67.2511 | 68 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 68.5724 | 69 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 64.9897 | 67 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 66.6183 | 68 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 174.566 | 82 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 98.4403 | 75 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 75.2038 | 71 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 141.027 | 80 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 84.9567 | 73 |